Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

Jie Qian,1,2,* Xueyan Zhang,2,* Bo Zhang,2 Bo Yan,2 Lin Wang,3 Ping Gu,2 Weimin Wang,2 Huimin Wang,2 Baohui Han2 1Department of Emergency Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Department of Pulmonary Medicine, Shanghai Ches...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Qian J, Zhang X, Zhang B, Yan B, Wang L, Gu P, Wang W, Wang H, Han B
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2020-05-01
Colecção:Cancer Management and Research
Assuntos:
lung adenocarcinoma
hepatotoxicity
tyrosine kinase inhibitor
gefitinib
erlotinib
icotinib
Acesso em linha:https://www.dovepress.com/tyrosine-kinase-inhibitor-related-hepatotoxicity-in-patients-with-adva-peer-reviewed-article-CMAR
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados